The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Innate Pharma ADR’s current trading price is -46.67% away from its 52-week high, while its distance from the 52-week low is 30.23%. The stock’s price range for this period has been between $1.29 and $3.15 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 11.83 million for the day, a number notably higher than the average daily volume of 11330.0 over the last three months.
Innate Pharma ADR ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $3.15 on 04/08/24, while the lowest value for the same period was recorded at $1.29 on 11/18/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Innate Pharma ADR (IPHA) has experienced a quarterly decline of -29.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 136.00M and boasts a workforce of 179 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0238, with a change in price of -0.4900. Similarly, Innate Pharma ADR recorded 126,723 in trading volume during the last 100 days, posting a change of -22.69%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IPHA stands at 1.23. Similarly, the long-term debt-to-equity ratio is also 0.92.
IPHA Stock Stochastic Average
As of today, Innate Pharma ADR’s raw stochastic average for the last 50 days stands at 38.00%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 53.52%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 33.80% and 26.88%, respectively.
IPHA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -40.00%. However, over the last six months, the performance has been stronger by -37.55%. The price of IPHA decreased -8.93% over the last 30 days. And in the last five days, it has surged by 15.07%.
